Kun Zhao (@drkunzhao) 's Twitter Profile
Kun Zhao

@drkunzhao

Postdoctoral researcher in @VUMChealth | Bick Lab | he/him/his

ID: 1579318628352110592

calendar_today10-10-2022 03:51:26

70 Tweet

43 Followers

112 Following

Pradeep Natarajan (@pnatarajanmd) 's Twitter Profile Photo

A great cover letter can make or break your manuscript submission. As an editor and author, I've seen how a strong cover letter helps editors grasp your paper’s significance. 🧵 [1/9]

Brett Heimlich (@brettheimlich) 's Twitter Profile Photo

Seeing this in real time at VUMC where 1 in 5 cath lab patients have CHIP. We're building care pathways but standardization across centers would help. Curious what others are doing for longitudinal follow-up. Michael Raddatz Pradeep Natarajan Alex Bick

Alyssa Parker (@alyssa_c_parker) 's Twitter Profile Photo

CHIP variants are often discovered incidentally in liquid biopsy testing, but is plasma cell-free DNA reliable when CHIP variants are the desired finding? 🩸Blood Advances Alex Bick 🧵1/12

Pradeep Natarajan (@pnatarajanmd) 's Twitter Profile Photo

Our study led by Ariel Xue & R. Bhattacharya, using targeted sequencing in the REPRIEVE clinical trial, shows that nearly 1 in 5 early middle-aged (mean 50y) adults living the HIV at low clinical cardiovascular risk have mutations indicative of clonal hematopoiesis.

Our study led by <a href="/ArielXue1/">Ariel Xue</a> &amp; R. Bhattacharya, using targeted sequencing in the REPRIEVE clinical trial, shows that nearly 1 in 5 early middle-aged (mean 50y) adults living the HIV at low clinical cardiovascular risk have mutations indicative of clonal hematopoiesis.